A detailed history of Versor Investments LP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Versor Investments LP holds 7,100 shares of ATRC stock, worth $293,443. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,100
Holding current value
$293,443
% of portfolio
0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$27.02 - $38.2 $191,842 - $271,220
7,100 New
7,100 $216,000
Q1 2023

May 05, 2023

BUY
$35.87 - $47.22 $233,944 - $307,968
6,522 New
6,522 $270,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.92B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.